Predictive biomarkers for systemic therapy of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Predictive biomarkers for systemic therapy of hepatocellular carcinoma

Published:2021-10-12 Issue:11 Volume:21 Page:1147-1164
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Moldogazieva Nurbubu T.¹^ORCID,Zavadskiy Sergey P.²^ORCID,Sologova Susanna S.²^ORCID,Mokhosoev Innokenty M.³^ORCID,Terentiev Alexander A.³^ORCID

Affiliation:

1. Laboratory of Bioinformatics, Institute of Translational Medicine and Biotechnology, I.m. Sechenov First Moscow State Medical University (Sechenov University);, Moscow, Russia

2. Department of Pharmacology, Nelyubin Institute of Pharmacy, I.m. Sechenov First Moscow State Medical University (Sechenov University), Russia, Russia

3. Department of Biochemistry and Molecular Biology, N.i. Pirogov Russian National Research Medical University, Moscow, Russia

Funder

First Moscow State Medical University Strategic Development Program under the Russian Academic Excellence Project

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2021.1987217

Reference163 articles.

1. Cancer statistics for the year 2020: An overview

2. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities